Sinai Medical Center Cedars serves as Executive at CAPRICOR THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Sinai Medical Center Cedars has executed 9 insider transactions totaling $8.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 16, 2021 involved exercising options for 100,000 shares valued at $0.
Sinai Medical Center Cedars currently holds 692,500 shares of CAPRICOR THERAPEUTICS, INC. (CAPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sinai Medical Center Cedars has been a net buyer of CAPR stock. They have purchased $8.5M and sold $0 worth of shares.
Sinai Medical Center Cedars's most recent insider trade was on Mar 16, 2021, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 16, 2021 | RXDX | $0 | Conversion | 361,566 | $N/A | Discretionary |
| Mar 16, 2021 | RXDX | $0 | Conversion | 2,500,000 | $N/A | Discretionary |
| Mar 16, 2021 | RXDX | $0 | Conversion | 1,200,000 | $N/A | Discretionary |
| May 9, 2017 | CAPR | $3.5M | Purchase | 1,145,161 | $3.10 | Discretionary |
| Sep 21, 2016 | CAPR | $1.0M | Purchase | 312,500 | $3.20 | Discretionary |
| Mar 16, 2016 | CAPR | $1000.0K | Purchase | 416,666 | $2.40 | Discretionary |
| Jan 21, 2015 | CAPR | $3.0M | Purchase | 851,546 | $3.52 | Discretionary |